J Med Chem. 2003 Oct 9;46(21):4525-32.

The discovery of tadalafil: a novel and highly selective PDE5 inhibitor. 1: 5,6,11,11a-tetrahydro-1H-imidazo[1',5':1,6]pyrido[3,4-b]indole-1,3(2H)-dione analogues.

Daugan A, Grondin P, Ruault C, Le Monnier de Gouville AC, Coste H, Kirilovsky J, Hyafil F, Labaudinière R.

Source

Laboratoire GlaxoSmithKline, Centre de Recherches, 25-27 Avenue du Québec, 91951 Les Ulis Cedex, France. acd9791@gsk.com

Abstract

Starting from ethyl beta-carboline-3-carboxylate (beta-CCE), 1, a modest inhibitor of type 5 phosphodiesterase (PDE5), a series of functionalized tetrahydro-beta-carboline derivatives has been identified as a novel chemical class of potent and selective PDE5 inhibitors. Optimization of the side chain on the hydantoin ring of initial lead compound 2 and of the aromatic ring on position 5 led to the identification of compound 6e, a highly potent and selective PDE5 inhibitor, with greater selectivity for PDE5 vs PDE1-4 than sildenafil. Compound 6e demonstrated a long-lasting and significant blood pressure lowering effect after iv administration in the spontaneously hypertensive rat model but showed only moderate oral in vivo efficacy.

PMID:: 14521414; [PubMed - indexed for MEDLINE]

LinkOut - more resources

Full Text Sources

Chemical Information

BindingDB

Supplemental Content

Related citations

The discovery of tadalafil: a novel and highly selective PDE5 inhibitor. 2: 2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione analogues. [J Med Chem. 2003]
The discovery of tadalafil: a novel and highly selective PDE5 inhibitor. 2: 2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione analogues.
Daugan A, Grondin P, Ruault C, Le Monnier de Gouville AC, Coste H, Linget JM, Kirilovsky J, Hyafil F, Labaudinière R. J Med Chem. 2003 Oct 9; 46(21):4533-42.
Potent tetracyclic guanine inhibitors of PDE1 and PDE5 cyclic guanosine monophosphate phosphodiesterases with oral antihypertensive activity. [J Med Chem. 1997]
Potent tetracyclic guanine inhibitors of PDE1 and PDE5 cyclic guanosine monophosphate phosphodiesterases with oral antihypertensive activity.
Ahn HS, Bercovici A, Boykow G, Bronnenkant A, Chackalamannil S, Chow J, Cleven R, Cook J, Czarniecki M, Domalski C, et al. J Med Chem. 1997 Jul 4; 40(14):2196-210.
Design, synthesis and structure-activity relationship of functionalized tetrahydro-β-carboline derivatives as novel PDE5 inhibitors. [Arch Pharm (Weinheim). 2011]
Design, synthesis and structure-activity relationship of functionalized tetrahydro-β-carboline derivatives as novel PDE5 inhibitors.
Ahmed NS, Gary BD, Tinsley HN, Piazza GA, Laufer S, Abadi AH. Arch Pharm (Weinheim). 2011 Mar; 344(3):149-57. Epub 2010 Dec 22.
Review Phosphodiesterase-5 inhibitors and their hemodynamic effects. [Curr Hypertens Rep. 2006]
Review Phosphodiesterase-5 inhibitors and their hemodynamic effects.
Prisant LM. Curr Hypertens Rep. 2006 Aug; 8(4):345-51.
Review Phosphodiesterase 5 inhibitors--drug design and differentiation based on selectivity, pharmacokinetic and efficacy profiles. [Curr Pharm Des. 2006]
Review Phosphodiesterase 5 inhibitors--drug design and differentiation based on selectivity, pharmacokinetic and efficacy profiles.
Supuran CT, Mastrolorenzo A, Barbaro G, Scozzafava A. Curr Pharm Des. 2006; 12(27):3459-65.

See reviews... See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
BioAssay
PubChem BioAssay experiments on the biological activities of small molecules that cite the current articles. The depositors of BioAssay data provide these references.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.

Recent activity

Clear Turn Off Turn On

The discovery of tadalafil: a novel and highly selective PDE5 inhibitor. 1: 5,6,...
The discovery of tadalafil: a novel and highly selective PDE5 inhibitor. 1: 5,6,11,11a-tetrahydro-1H-imidazo[1',5':1,6]pyrido[3,4-b]indole-1,3(2H)-dione analogues.
J Med Chem. 2003 Oct 9 ;46(21):4525-32.

PubMed
Potency, selectivity, and consequences of nonselectivity of PDE inhibition.
Potency, selectivity, and consequences of nonselectivity of PDE inhibition.
Int J Impot Res. 2004 Jun ;16 Suppl 1:S11-4.

PubMed
Development of Z-scores for fetal cardiac dimensions from echocardiography.
Development of Z-scores for fetal cardiac dimensions from echocardiography.
Ultrasound Obstet Gynecol. 2005 Nov ;26(6):599-605.

PubMed
Evaluation of cardiovascular risk in school children.
Evaluation of cardiovascular risk in school children.
Bosn J Basic Med Sci. 2009 Aug ;9(3):182-6.

PubMed
Temporal and spatial variability of personal exposure to radio frequency electro...
Temporal and spatial variability of personal exposure to radio frequency electromagnetic fields.
Environ Res. 2009 Aug ;109(6):779-85. Epub 2009 May 23 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to:

The discovery of tadalafil: a novel and highly selective PDE5 inhibitor. 1: 5,6,11,11a-tetrahydro-1H-imidazo[1',5':1,6]pyrido[3,4-b]indole-1,3(2H)-dione analogues.

Source

Abstract

MeSH Terms, Substances

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Chemical Information

Supplemental Content

Related citations

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information